# Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers

> **NCT02551744** · NA · COMPLETED · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 101 (actual)

## Conditions studied

- Peptic Ulcer

## Interventions

- **DRUG:** histamine-2 receptor antagonist group
- **DRUG:** proton pump inhibitor group

## Key facts

- **NCT ID:** NCT02551744
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2018-07
- **Final completion:** 2018-07
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2019-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02551744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02551744, "Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02551744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*